A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
IN ONCOLOGY
WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.
WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS
MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.
MEDSIR favors a collaborative approach for clinical development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.
TOGETHER WE CAN BUILD A BRIGHTER FUTURE
WHAT WE DO
Our international team of high-level clinicians and research experts are passionate about collaborating with medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.
MEDSIR IN NUMBERS
>29
INDUSTRY FUNDERS
>200
SITES
>40
TRIALS DEVELOPED
>300
RESEARCH
COLLABORATORS
>400
IDEAS
GENERATED
>80
STAFF
DEDICATED
>2000
PATIENTS
RECRUITED
OUR STUDIES
Some examples of MEDSIR ideas matured into strategic clinical trials.
PHERGAIN
BREAST
Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: A FDG-PET response-adapted strategy
ORPHEUS
PENIS
Phase II Study of the Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma
PARSIFAL
BREAST
Palbociclib with fulvestrant or letrozole for HER-, ER+ metastatic breast cancer
